Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis

Protein Science

Volumn 9, Issue 3, 2000, Pages 487-496

  Hochleitner, Elisabeth O ^a   Borchers, Christoph ^a   Parker, Carol ^a   Bienstock, Rachelle J ^a   Tomer, Kenneth B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acetylation; Differential chemical modification; Discontinuous epitope; HIV p24; Mass spectrometry

Indexed keywords

ANTIGEN P24; CORE PROTEIN; EPITOPE;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034067250     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.3.487     Document Type: Article

References (31)

1. Asara JM, Allison J. 1998. Enhanced detection of phosphopeptides in matrix-assisted laser desorption/ionization mass spectrometry using ammonium salts. J Am Soc Mass Spectrom 10:35-44.
2. Borchers C, Parker CE, Deterding LJ, Tomer KB. 1999. A preliminary comparison of precursor scans and LC/MS/MS on a hybride quadrupole time of flight mass spectrometer. J Chromatogr A 854:119-130.
3. th ASMS conference on mass spectrometry and allied topics. June 1-5, 1997, Palm Springs, California.
4. Burnens A, Demotz G, Corradin G, Binz H, Bosshard HR. 1987. Epitope mapping by chemical modification of free and antibody bound protein antigen. Science 235:780-783.
5. Chen J, Smith DL, Griep M. 1998. The role of 6 lysines and the terminal amine of Escherichia coli single strand binding protein in its binding of single-stranded DNA. Protein Sci 7:1781-1788.
6. Chou MJ, Lee TH, Hatzakis A, Mandalaki T, McLane MF, Essex M. 1988. Antibody response in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis 157(4):805-811.
7. Davies DR, Cohen GH. 1996. Review: Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA 93:7-12.
8. Debouck C, Gorniak JG, Strickler JE, Meek TD, Metcalf BW, Rosenberg M. 1987. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Natl Acad Sci USA 84(24):8903-8906.
9. Ehrhard B, Misselwitz R, Welfle K, Hausdorf G, Glaser RW, Schneider-Mergener J, Welfle H. 1996. Chemical modification of recombinant HIV-1 capsid protein p24 leads to the release of a hidden epitope prior to changes of the overall folding of the protein. Biochemistry 35(28):9097-9105.
10. Fiedler W, Borchers C, Macht M, Deininger SO, Przybylski M. 1998. Molecular characterization of a conformational epitope of hen egg white lysozyme by differential chemical modification of immune complexes and mass spectrometric peptide mapping. Bioconjug Chem 9:236-241.
11. Gaines H, Soennerborg A, Czajkowki J, Chiodi F, Fenyoe EM, von Sydow M, Albert J, Pehrson PO, Moberg L, Asjoe B, Forsgen M. 1987. Antibody response in primary human immunodeficiency virus infection. Lancet 30:1249-1253.
12. Gelderblom HR, Hausmann EH, Ozel M, Pauli G, Koch MA. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156(1):171-176.
13. Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235.
14. Glazer AN. 1970. Specific chemical modification of proteins. Annu Rev Biochem 39:101-130.
15. Glocker MO, Borchers C, Fiedler W, Suckau D, Przybylski M. 1994. Molecular characterization of surface topology in protein tertiary structures by amino-acetylation and mass spectrornetric peptide mapping. Bioconjug Chem 5:583-590.
16. Gurtler L, Muhlbacher A, Michl U, Hofmann H, Paggi GG, Bossi V, Thorstensson R, Villaecusa R, Eiras A, Hernandez JM, et al. 1998. Reduction of the diagnostic window with a combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods 75(1):27-38.
17. Healey DS, Maskill WJ, Neate EV, Beaton F, Gust ID. 1988. A preliminary evaluation of five HIV antigen detection assays. J Virol Methods 20:115-125.
18. Jackson RM. 1999. Comparison of protein-protein interactions in serine protease-inhihitor and antibody-antigen complexes: Applications for the protein docking problem. Protein Sci 8:603-613.
19. Janvier B, Lasarte JJ, Sarobe P, Hoebeke J, Baillou-Beaufils A, Borras-Cuesta F, Barin F. 1996. B cell epitopes of HIV Type 1 p24 capsid protein: A reassessment. Aids Res Hum Retr 12(6):516-524.
20. Jemmersen R, Paterson Y. 1986. Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes. Science 232:1001-1004.
21. Jeyarajah S, Parker CE, Sumner MT, Tomer KB. 1998. Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody. J Am Soc Mass Spectrom 9:157-165.
22. Keitel T, Kramer A, Wessner H, Scholz C, Schneider-Mergener J, Hohne W. 1997. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 91:811-820.
23. Misselwitz R, Hausdorf G, Welfle K, Hoehne WE, Welfle H. 1995. Conformation and stability of recombinant HIV-1 capsid protein p24 (rp24). Biochim Biophys Acta 1250:9-18.
24. Parker CE, Papac DI, Trojak SK, Tomer KB. 1996. Epitope mapping by mass spectrometry. J Immunol 157:198-206.
25. Reicin AS, Ohagen A, Yin L, Hoglung S, Goff SP. 1996. The role of gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J Virol 70(12):8645-8652.
26. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: Effects on virion particle assembly, release, and infectivity. J Virol 69: 642-650.
27. Suckau D, Mak M, Przybylski M. 1992. Protein surface topology-probing by selective chemical modification and mass spectrometric peptide mapping. Proc Natl Acad Sci USA 89:5630-5634.
28. Vasudevachari MB, Uffelman KW, Mast TC, Dewar RL, Natarajan V, Lane HC, Salzman NP. 1989. Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and western blot (immunoblot) analysis. J Clin Microbiol 27(1):179-181.
29. Wang F, Blanchard JS, Tang A. 1997. Hydrogen exchange/electrospray ionization mass spectrometry studies of substrate and inhibitor binding and conformational changes of Escherichia coli dihydropicolinate reductase. Biochemistry 36(13):3155-3759.
30. Watkins BA, Buge S, Aldrich K, Davies AE, Robinson J, Reitz MS, Robert-Guroff M. 1996. Resistance of human immunodeficiency virus type 1 to neutralization by natural sera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites. J Virol 70(12): 8431-8437.
31. Wilm M, Neubauer G, Mann M. 1996. Parent ions scans of unseparated peptide mixtures. Anal Chem 68:527-533.